Meanwhile, in non-Trump, non-impeachment and non-speaker news – Roll Call

Podcasts

Meanwhile, in non-Trump, non-impeachment and non-speaker news

Political Theater, Episode 322

Sen. Bob Menendez, D-N.J., did not raise much money for his reelection campaign, but he did for his legal defense. Still, he might run anyway in November, potentially upending Garden State politics. — Sen. Bob Menendez, D-N.J., did not raise much money for his reelection campaign, but he did for his legal defense. Still, he might run anyway in November, potentially upending Garden State politics. (Tom Williams/CQ Roll Call)

By Jason Dick and Herb Jackson

Posted April 19, 2024 at 9:00am

Granted, FEC filings will always play second banana to a former president’s criminal trial, Senate consideration of impeachment articles against a Cabinet secretary and drama over a slow-moving leadership coup in the House, but they do offer a glimpse of how the 2024 House and Senate campaigns are shaping up in an election with big consequences. Come for the analysis, stay for musings about Jersey and Arizona.

Show Notes:

Recent Stories

Anthea Hartig, director of the National Museum of American History, is sworn in for a House Oversight and Government Reform subcommittee hearing Tuesday.

Republicans in Congress probe history museum, echoing Trump

Capitol Lens | Upon reflection

President Donald Trump addresses the nation from the East Room of the White House on Thursday evening. (SAUL LOEB / POOL / AFP via Getty Images)

Independent voters have been skeptical of Trump’s election claims

Flowers honoring the late Sen. Lindsey Graham, R-S.C., are seen during a Senate Judiciary Committee hearing on July 16.

Rotunda tribute and Cathedral funeral announced for Lindsey Graham

White House counselor Peter Navarro speaks during a news conference outside the USDA Whitten Building on Tuesday, July 8, 2025.

Appeals court upholds contempt of Congress conviction for Navarro

Rep. John Joyce, R-Pa., leaves the Capitol Hill Club after a meeting of the House Republican Conference on Tuesday, March 4, 2025.

Competing bills aim for elusive changes to drug discount program